StonvexLoading…
StonvexStonvexStonvexCore line items from ASTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $13.82M | $13.82M | $12.40M | $5.97M |
Operating Income | $-525.00M | $-102.50M | $-72.93M | $-1.12M |
Net Income | $-300.08M | $-31.64M | $-30.55M | $-51.96M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $954.56M | $438.37M | $443.94M | $99.64M |
Total Liabilities | $285.42M | $78.55M | $91.96M | $19.66M |
Cash & Equivalents | $564.99M | $238.59M | $321.79M | $42.78M |
Free Cash Flow OCF − CapEx | $-300.27M | $-213.75M | $-95.17M | $-30.93M |
Shares Outstanding | 154.50M | Not available | Not available | Not available |